FGK expands eastwards
Prague – After increasing its investment in mid-January, full-service provider CRO FGK Clinical Research GmbH has become a major shareholder in the Czech contract research organization Avemedica s.r.o. Financial details were not disclosed. With immediate effect, the Czech specialist for project management and monitoring of Phase II-IV trials will operate as FGK Clinical Research s.r.o. With the takeover, FGK Clinical Research intends to strengthen its European network. The new company is specialised in local services in the areas of regulatory affairs, project management and monitoring for their customers from pharmaceutical, biotechnology and medical device companies in the Czech Republic and Slovakia.